Pharmacy

Your Article Summary

See Latest Articles

Novel drug delivery strategies in neuro-oncology
Neurotherapeutics, 07/01/09

Bidros DS et al. - In a review of novel drug delivery strategies in neuro-oncology, this article will describe the clinically available methods used to circumvent the blood brain barrier and summarize results to date of ongoing and completed clinical trials.

• Treatment of malignant gliomas represents 1 of the most formidable challenges in oncology.
• Despite treatment with surgery, radiation therapy, and chemotherapy, the prognosis remains poor, particularly for glioblastoma, which has a median survival of 12 to 15 mos.
• An important impediment to finding effective treatments for malignant gliomas is the presence of the blood brain barrier, which serves to prevent delivery of potentially active therapeutic compounds.

• Multiple efforts are focused on developing strategies to effectively deliver active drugs to brain tumor cells.
• Blood brain barrier disruption and convection-enhanced delivery have emerged as leading investigational delivery techniques for treatment of malignant brain tumors.
• Clinical trials using these methods have been completed, with mixed results, and several more are being initiated.

Related Articles

See all related articles

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Trends in Pharmacological Sciences, 10/29/09    Relevance Score: 68%

Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
The International Journal of Tuberculosis and Lung Disease, 11/19/09    Relevance Score: 67%

Optimized inhaler mouthpiece design allows for more effective drug delivery
EurekAlert, 10/22/09    Relevance Score: 67%

Value-Based Insurance Design in Medicare
Applied Health Economics and Health Policy, 10/20/09    Relevance Score: 67%

A Comparison of Phase II Study Strategies
Clinical Cancer Research, 10/01/09    Relevance Score: 67%

Today in Chemotherapy/Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors
Chemotherapy, 12/11/09

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
The Lancet - Early Online Publication, 12/11/09

A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09

 See all of Chemotherapy/Oncology